Company Filing History:
Years Active: 2022-2023
Title: Inventor Spotlight on Daniel F. Milano
Introduction
Daniel F. Milano, an innovative inventor based in Reading, Massachusetts, has made significant contributions to the field of biopharmaceuticals. With a focus on improving drug delivery through advanced conjugation methods, he holds two patents that showcase his expertise in this cutting-edge area.
Latest Patents
Daniel's latest patents include:
1. **Methods of Preparing Cell-Binding Agent-Drug Conjugates**: This invention outlines methods for constructing a cell-binding agent-cytotoxic agent conjugate. It features a cell-binding agent with unpaired cysteine residues linked covalently to a cytotoxic agent. Additionally, the patent provides insights into the resulting conjugates and their pharmaceutical applications.
2. **Methods for Antibody Drug Conjugation, Purification, and Formulation**: This patent presents innovative methods for producing, purifying, and formulating antibody drug conjugates (ADCs). Utilizing continuous conjugation processes and advanced filtration techniques, these methods aim to reduce process times and costs while enhancing product consistency, marking a notable advancement in biopharmaceutical manufacturing.
Career Highlights
Daniel F. Milano is currently employed at ImmunoGen, Inc., a leading biotechnology company focused on developing targeted cancer therapies. His role at ImmunoGen underscores his commitment to pioneering new methods that enhance therapeutic efficacy through targeted drug delivery systems.
Collaborations
Throughout his career, Daniel has collaborated with talented professionals such as Scott A. Hilderbrand and Michael Reardon. These partnerships highlight the collaborative spirit necessary for driving innovation and developing successful biopharmaceutical solutions.
Conclusion
With a strong focus on innovative drug conjugation techniques, Daniel F. Milano is a noteworthy figure in the biopharmaceutical industry. His patents reflect a dedication to advancing cancer treatments, demonstrating how one inventor can significantly impact therapeutic strategies through innovation.